Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the ...

Q4 2024 adjusted EPS* above the high end of the guidance range; Raising 2025 annual outlook(All amounts in U.S. dollars) TORONTO, Ja ...

Fairfax Financial, a Canadian insurer founded by Prem Watsa, follows a model similar to Berkshire Hathaway. Read why we are ...

Roche projects mid-single digit group sales growth in 2025, with core EPS growth in the high-single digit range. The company expects a CHF1.2 billion impact from the loss of exclusivity but aims to ...

Commentary: Apple needs its iPhone 17 cameras to seriously impress. This is how it could do it.

Vetoquinol's sales for FY 2024 came to ¬539 million, up 1.9 % on a reported basis and 2.2% at constant exchange rates. Exchange rates had a negative impact of -¬1.9 million.

The outperformance of the US stock market against its global peers in recent years is widely commented on, as well as the ever-widening gap between valuation multiples in the US and elsewhere – ...